Web30 gen 2024 · Beyond Zika, Takeda is pursuing several vaccine programs to address high-priority infectious diseases, including dengue, norovirus and polio. Takeda’s dengue vaccine candidate, TAK-003, was also granted Fast Track designation and is currently being evaluated in a pivotal Phase 3 efficacy study, with initial data expected this year. WebA Zika virus vaccine is designed to prevent the symptoms and complications of Zika virus infection in humans. As Zika virus infection of pregnant women may result in congenital defects in the newborn, the vaccine will attempt to protect against congenital Zika syndrome during the current or any future outbreak. As of April 2024, no vaccines have been …
Takeda Pharmaceuticals enters race for a Zika vaccine - STAT
Web30 lug 2024 · Takeda is heavily focused on its global vaccine business, including its lead candidate for dengue, COVID-19, pandemic influenza, and Zika targets. The company had an NDA accepted for Priority Review in May with the potential to become the first and only treatment approved for cytomegalovirus infection in refractory patients. Web12 apr 2024 · Today, Takeda's global vaccine business is applying innovation to tackle some of the world's most challenging infectious diseases, such as dengue, COVID-19, Zika and norovirus. Takeda’s team brings an outstanding track record and a wealth of knowledge in vaccine development, manufacturing and global access to advance a pipeline of … greatspine boundary xenoblade 2
Takeda and IDT Support Manufacturing of Johnson & Johnson’s …
Web28 nov 2024 · Takeda’s investigational Zika virus vaccine candidate (TAK-426) progresses into Phase 1 clinical trial; The clinical trial (ZIK-101) will evaluate safety and immunogenicity of TAK-426 in 240 ... WebBut even after the WHO stopped classifying Zika as an "emergency" in late 2016, Takeda pressed ahead with its program, this week winning the FDA's fast-track designation. Web13 apr 2024 · Today, Takeda's global vaccine business is applying innovation to tackle some of the world's most challenging infectious diseases, such as dengue, COVID-19, Zika and norovirus. Takeda’s team brings an outstanding track record and a wealth of knowledge in vaccine development, manufacturing and global access to advance a pipeline of … florence lodges tenby